This manuscript reviews the recent progress on mesoporous silica nanoparticles as drug
delivery systems. Their intrinsic structural, textural and chemical features permit to design …

The present review details a chronological description of the events that took place during
the development of mesoporous materials, their different synthetic routes and their use as …

In recent years, nanomedicine has emerged at the forefront of nanotechnology, generating
great expectations in the biomedical field. Researchers are developing novel nanoparticles …

The versatile potential of mesoporous silica nanoparticles (MSNs) as drug delivery agents
for cytotoxic or chemically sensitive (macro) molecules has been demonstrated in numerous …

Since the first report of mesoporous silica nanoparticles in 2001, many efforts have been
made to develop them for biomedical applications. With the emergence of new designs and …

Recent advancements in drug delivery technologies utilizing a variety of carriers have
resulted in a path-breaking revolution in the approach towards diagnosis and therapy alike …

Due to the theragnostic potential of mesoporous silica nanoparticles (MSNs), these were
extensively investigated as a novel approach to improve clinical outcomes. Boasting an …

This tutorial review provides an outlook on nanomaterials that are currently being used for
theranostic purposes, with a special focus on mesoporous silica nanoparticle (MSNP) based …

Mesoporous silica nanoparticles (MSNPs) are a particular example of innovative
nanomaterials for the development of drug delivery systems. MSNPs have recently received …

Modern nanomedicine aims at delivering drugs or cells specifically to defective cells;
therefore, this calls for developing multifunctional nanocarriers for drug delivery and cell …